Systemic lupus erythematosus. Recognizing its various presentations

Area of Science:

• Immunology
• Rheumatology

Background:

• Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with diverse clinical manifestations.
• Etiology involves a complex interplay of genetic predisposition, environmental factors, and immune dysregulation.
• SLE predominantly affects women, indicating potential hormonal or genetic influences.

Purpose of the Study:

• To provide a comprehensive overview of systemic lupus erythematosus (SLE).
• To outline the various causative factors and clinical presentations of SLE.
• To summarize current therapeutic strategies for managing SLE.

Main Methods:

• Literature review of systemic lupus erythematosus (SLE) pathogenesis, clinical features, and treatment modalities.
• Synthesis of information on genetic, environmental, and immunological factors contributing to SLE.
• Categorization of SLE manifestations across multiple organ systems.

Main Results:

• SLE presents with a wide spectrum of symptoms affecting skin, joints, cardiovascular, renal, pulmonary, gastrointestinal, neuropsychiatric, and hematologic systems.
• Identified probable causative factors include genetic predisposition, complement deficiencies, antigen persistence, drug exposure, and environmental triggers.
• Treatment approaches vary based on disease severity, utilizing nonsteroidal anti-inflammatory drugs and antimalarials for milder forms, and corticosteroids and cytotoxic agents for severe SLE.

Conclusions:

• Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune condition requiring a multi-faceted approach to management.
• Early diagnosis and tailored treatment are crucial for managing the diverse manifestations of SLE.
• Ongoing research into the pathogenesis of SLE is vital for developing more targeted therapies.